Abstract View

Author(s): Sayed Saziya F1, Khan Afreen2, Bushra Fatema3, Choudary Sumaiya4

Email(s): 1s.saziya003@gmail.com

Address:

    J.I.I.U’S Ali-Allana College of Pharmacy Akkalkuwa, Dist- Nandurbar (425415) Maharashtra, India.

Published In:   Volume - 3,      Issue - 1,     Year - 2024

DOI: Not Available

 View HTML        View PDF

Please allow Pop-Up for this website to view PDF file.

ABSTRACT:
Progeria is characterized by clinical features that mimic premature ageing. Although the mutation responsible for this syndrome has been deciphered, the mechanism of its action remains elusive. Progeria research has gained momentum particularly in the last two decades because of the possibility of revealing evidences about the ageing process in normal and other pathophysiological conditions. Various experimental models, both in vivo and in vitro, have been developed in an effort to understand the cellular and molecular basis of a number of clinically heterogeneous rare genetic disorders that come under the umbrella of progeroid syndromes (PSs). As per the latest clinical trial reports, Lonafarnib, a farnesyl tranferase inhibitor, is a potent ‘drug of hope’ for Hutchinson-Gilford progeria syndrome (HGPS) and has been successful in facilitating weight gain and improving cardiovascular and skeletal pathologies in progeroid children. This can be considered as the dawn of a new era in progeria research and thus, an apt time to review the research developments in this area highlighting the molecular aspects, experimental models, promising drugs in trial and their implications to gain a better understanding of PSs.

Cite this article:
Sayed Saziya F., Khan Afreen, Bushra Fatema, Choudary Sumaiya. Progeria: A rare Genetic Disorder. IJRPAS, 2024; 3(1): 71-76.


1.    Gordon, LB. The Premature Aging Syndrome Hutchinson-Gilford Progeria : Insights               into Normal Aging in: Brocklehurst’s Textbook of Geriatric Medicine and Gerontology, Seventh Edition. 2010: page no:66-72.

2.    What Is Progeria a.k.a. Hutchinson-Gilford Progeria         Syndrome (HGPS)? Dr. Hakim. K. Saboowala. 1 May 2016. Page no :09-20.

3.    Hutchinson-Gilford Progeria Syndrome Frequently Asked Questions. Progeria Research Foundation. Updated October 2020. Available at https://www.progeriaresearch.org/progeria-101faq/ Accessed December 23, 2020.

4.English-Progeria-Handbook-Edition-2.pdf. Updated March 2019. Available at https://www.progeriaresearch.org/patient-care-and-handbook/

5. Hutchinson-Gilford Progeria Syndrome. NORD Org. Updated 4th January, 2021. Available at https://rarediseases.org/

6.    Leslie B. GordonMonica E. KleinmanDavid T. Miller and Mark W. Kieran. Clinical trial of a farnesyltransferase inhibitor in children with Hutchinson–Gilford progeria syndrome. Updated September 24, 2012 . Available at https://doi.org/10.1073/pnas.1202529109

7.    https://www.pnas.org/

8.    Small-Molecule Therapeutic Perspectives for the Treatment of Progeria. Jon MaciciorBeatriz Marcos-Ramiro, and Silvia Ortega-Gutiérrez. Published on Jul 3, 2021. Available at https://www.ncbi.nlm.nih.gov/

9.    www.progeriaresearchfoundation.com

10.    Progeria: A rare genetic premature ageing disorder , Jitendra Kumar Sinha, Shampa Ghosh, and Manchala R., 2014 May, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4140030/

 

Related Images:



Recent Images



Preparation, Characterisation and Evaluation of Herbal Nanoparticles of Shorea robusta for Pharmacological Activity
Preparation and Evaluation of Winter Care Soap
Cardiovascular Targeted Herbal Delivery Via Skin using Herbal Patches: A Comprehensive Review
Correlation of Central Corneal Thickness (CCT) and Intraocular Pressure (IOP) in Myopes and Hyperopes
Patients’ Utilization and Perspective Towards Adopting Strategies to Improve Medication Adherence
Pharmacological Evaluation of Daucus carota for its Hepatoprotective and Antioxidant Activity
Behind The Bump: The Hidden Phobia of Pregnancy, Tokophobia
Emerging Mechanistic Insights Into Targeted Nanocarrier-Mediated Cancer Drug Delivery: Challenges, Innovations, And Translational Perspectives
Formulation and In-Vitro Characterization of Oral Nanocrystals of Meloxicam
Evaluation and in vitro assessment physical characterization of the oral Colloidal Nano particulate dispersion of Atorvastatin calcium and therapeutic efficacy by improving its solubility.

Tags


Recomonded Articles:

Author(s): Mr. Pawar Jaydeep*; Mr. Yalse Manoj; Mr. Sonawane Sumit; Miss. Vasave Vibhuti.

DOI: https://doi.org/10.71431/IJRPAS.2025.4309         Access: Open Access Read More

Author(s): Magendran Rajendiran1*, Muruganand R2, Abhisek Kumar Sinha2, Mohamed Raashith M S2, Jasitha Begam M2, Usharani G2, Dhivyari D2, Deepika T2

DOI: https://doi.org/10.71431/IJRPAS.2025.4413         Access: Open Access Read More

Author(s): Bhagyashri C. Patel; Sandhya R. Chavhan; H.P. Suryawanshi; R. A. Ahirrao

DOI:         Access: Open Access Read More

Author(s): Pravin V. Gomase; R. R. Patil; Sunil P. Pawar

DOI: NA         Access: Open Access Read More

Author(s): Moyeda Asha jyothi*; Gollapalli Surendra kumar; Atru Naga Swarna; Dr. Ch.P.S.R. Madhuri; Dr. G. Sumalatha

DOI: https://doi.org/10.71431/IJRPAS.2025.4205         Access: Open Access Read More

Author(s): Krushna A. Zagade*, Manolikar Megha. A, Kadam Akash. R, Paul Pratiksha. B, Dr.R.D Ingole

DOI: https://doi.org/10.71431/IJRPAS.2025.4512         Access: Open Access Read More

Author(s): Kamil Hafiz Anees Ahmed Quazi; Dr. Majaz Quazi; Wasil Jalees Quazi; Dr. G. J. Khan.

DOI:         Access: Open Access Read More

Author(s): Mudigonda Sowjanya*; Nishad, Fariya; Malla Rajeshwari; Dr. K. Lakshmi Surekha

DOI:         Access: Open Access Read More

Author(s): Patil Aachal*; Nusrat Khan

DOI:         Access: Open Access Read More

Author(s): Mohammad Vakar*; Shaikh Imran Kalam; Dr. G.J. Khan; M Sohil M Shabbir; Aman Shaikh; Shaikh Md. Moiz

DOI:         Access: Open Access Read More

Author(s): Kazi Kaif Aarefoddin; Mohommad Altamash*; Abdullah Danish

DOI: https://doi.org/10.71431/IJRPAS.2025.4313         Access: Open Access Read More

Author(s): Soni Rishita1*, Salunke Khushi1, Patel Harsh1, Patel Aastha1, Taufik Mulla2, Ambika Nand Jha3

DOI:         Access: Open Access Read More

Author(s): Krushna A. Zagade*, Shaikh Usman M., Panchal Krushna S., Wavhale Sharda S., Dr. R. D. Ingole

DOI: https://doi.org/10.71431/IJRPAS.2025.4508         Access: Open Access Read More

Author(s): Hasanen Pinjari; Rehan Deshmukh; Khan Faizan; Dr. Gulam Javed.

DOI:         Access: Open Access Read More

Author(s): Mugdivari Sangeetha*; Balemla Sada; Kunal Bohara; Syed Yaseen Pasha; Yerram Shravya; Tadikonda Rama Rao

DOI: https://doi.org/10.71431/IJRPAS.2025.4605         Access: Open Access Read More

Author(s): Rupesh S. Shirude*, Huzaif A. Shaikh, Shakir Ansari, Mr. T.F. Sayyad

DOI: https://doi.org/10.71431/IJRPAS.2025.4407         Access: Open Access Read More

Author(s): Ms. Harsha S. Suryawanshi; Ms. Nikita S. Patil; Mr. Azam Z. Shaikh; Dr. S. P. Pawar

DOI:         Access: Open Access Read More

Author(s): Kalyani P.Patil; Damini M.Patil; Sunila A.Patil; Sunil.P.Pawar.

DOI:         Access: Open Access Read More

Author(s): S. Sathya, Karthiga. D, Lokesh. S, Sabari Manikandan, V. R. Rajeswari

DOI: https://doi.org/10.71431/IJRPAS.2025.4105         Access: Open Access Read More

Author(s): Sonawane Shubham B*; Sonawane Kalpesh B.; Somvanshi D.; Sonawane Varun S.; Prof. Sayyad Tahir F.

DOI: https://doi.org/10.71431/IJRPAS.2025.4410         Access: Open Access Read More